Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Victoria Mateos

Showing results (151-160 of 211) with videos related to

Pageof 22
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2024
Minimally Invasive Assessment of Peripheral Residual Disease During Maintenance or Observation in Transplant-Eligible Patients With Multiple MyelomaMarta Lasa, Laura Notarfranchi, Cristina Agullo, et al.
JAMA Oncology|August 12, 2018
Maintenance Treatment and Survival in Patients With Myeloma: A Systematic Review and Network Meta-analysisFrancesca Gay, Graham Jackson, Laura Rosiñol, et al.
Leukemia|August 21, 2020
Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma NetworkHeinz Ludwig, Mario Boccadoro, Philippe Moreau, et al.
Blood|September 6, 2019
Bortezomib, lenalidomide, and dexamethasone as induction therapy prior to autologous transplant in multiple myelomaLaura Rosiñol, Albert Oriol, Rafael Rios, et al.
Blood Advances|September 29, 2021
FlowCT for the analysis of large immunophenotypic data sets and biomarker discovery in cancer immunologyCirino Botta, Catarina Maia, Juan-José Garcés, et al.
The Lancet. Oncology|May 31, 2024
Consensus guidelines and recommendations for the management and response assessment of chimeric antigen receptor T-cell therapy in clinical practice for relapsed and refractory multiple myeloma: a report from the International Myeloma Working Group Immunotherapy CommitteeYi Lin, Lugui Qiu, Saad Usmani, et al.
Journal for Immunotherapy of Cancer|March 6, 2026
Antibiotic-associated dysbiosis and bispecific antibody outcomes in multiple myelomaMagdalena Corona, Roberto García-Vicente, Adolfo Jesús Saez-Marin, et al.
The Lancet. Oncology|July 6, 2023
Management of multiple myeloma-related renal impairment: recommendations from the International Myeloma Working GroupMeletios A Dimopoulos, Giampaolo Merlini, Frank Bridoux, et al.
American Journal of Hematology|April 7, 2022
Monoclonal gammopathy of renal significance (MGRS): Real-world data on outcomes and prognostic factorsAlessandro Gozzetti, Andrea Guarnieri, Elena Zamagni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2022
Circulating Tumor Cells for the Staging of Patients With Newly Diagnosed Transplant-Eligible Multiple MyelomaJuan-Jose Garcés, Maria-Teresa Cedena, Noemi Puig, et al.
Pageof 22

Showing results (151-160 of 211) with videos related to

Sort By:
Pageof 22
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2024
Minimally Invasive Assessment of Peripheral Residual Disease During Maintenance or Observation in Transplant-Eligible Patients With Multiple MyelomaMarta Lasa, Laura Notarfranchi, Cristina Agullo, et al.
JAMA Oncology|August 12, 2018
Maintenance Treatment and Survival in Patients With Myeloma: A Systematic Review and Network Meta-analysisFrancesca Gay, Graham Jackson, Laura Rosiñol, et al.
Leukemia|August 21, 2020
Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma NetworkHeinz Ludwig, Mario Boccadoro, Philippe Moreau, et al.
Blood|September 6, 2019
Bortezomib, lenalidomide, and dexamethasone as induction therapy prior to autologous transplant in multiple myelomaLaura Rosiñol, Albert Oriol, Rafael Rios, et al.
Blood Advances|September 29, 2021
FlowCT for the analysis of large immunophenotypic data sets and biomarker discovery in cancer immunologyCirino Botta, Catarina Maia, Juan-José Garcés, et al.
The Lancet. Oncology|May 31, 2024
Consensus guidelines and recommendations for the management and response assessment of chimeric antigen receptor T-cell therapy in clinical practice for relapsed and refractory multiple myeloma: a report from the International Myeloma Working Group Immunotherapy CommitteeYi Lin, Lugui Qiu, Saad Usmani, et al.
Journal for Immunotherapy of Cancer|March 6, 2026
Antibiotic-associated dysbiosis and bispecific antibody outcomes in multiple myelomaMagdalena Corona, Roberto García-Vicente, Adolfo Jesús Saez-Marin, et al.
The Lancet. Oncology|July 6, 2023
Management of multiple myeloma-related renal impairment: recommendations from the International Myeloma Working GroupMeletios A Dimopoulos, Giampaolo Merlini, Frank Bridoux, et al.
American Journal of Hematology|April 7, 2022
Monoclonal gammopathy of renal significance (MGRS): Real-world data on outcomes and prognostic factorsAlessandro Gozzetti, Andrea Guarnieri, Elena Zamagni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2022
Circulating Tumor Cells for the Staging of Patients With Newly Diagnosed Transplant-Eligible Multiple MyelomaJuan-Jose Garcés, Maria-Teresa Cedena, Noemi Puig, et al.
Pageof 22